These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27030614)

  • 41. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
    Van't Hof AW; Ten Berg J; Heestermans T; Dill T; Funck RC; van Werkum W; Dambrink JH; Suryapranata H; van Houwelingen G; Ottervanger JP; Stella P; Giannitsis E; Hamm C;
    Lancet; 2008 Aug; 372(9638):537-46. PubMed ID: 18707985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of tirofiban in acute anterior myocardial infarction patients without ST segment resolution after primary percutaneous coronary intervention].
    Peng JJ; Ma ZM; Ren LH; Ma ZM; Ren LH; Fu GQ; Jia KY; Lei LC; Ye HM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):725-8. PubMed ID: 20021927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet inhibition by increased tirofiban dosing during primary coronary angioplasty for ST elevation myocardial infarction.
    Kralisz P; Dobrzycki S; Nowak K; Kochman W; Gajewska-Bachórzewska H; Gugała K; Mezyński G; Prokopczuk P; Zuk J; Korecki J; Poniatowski B; Musiał W
    Kardiol Pol; 2004 May; 60(5):459-67. PubMed ID: 15247961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of intracoronary tirofiban administration in patients with serious thrombus burden and ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
    Wang HL; Xing SY; Dong PS; Han YH; Zhu JH; Lai LH; Zhao JF
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3690-5. PubMed ID: 25535142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tirofiban use with clopidogrel and aspirin decreases adverse cardiovascular events after percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
    Sethi A; Bahekar A; Doshi H; Bhuriya R; Bedi U; Singh S; Khosla S
    Can J Cardiol; 2011; 27(5):548-54. PubMed ID: 21871775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved outcomes from transradial over transfemoral access in primary percutaneous coronary intervention for patients with acute ST-segment elevation myocardial infarction and upstream use of tirofiban.
    Zhang Q; Qiu JP; Zhang RY; Hu J; Yang ZK; Ding FH; DU R; Zhu TQ; Zhang JS; Shen WF
    Chin Med J (Engl); 2013 Mar; 126(6):1063-8. PubMed ID: 23506579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome.
    Smit JJ; Ernst NM; Slingerland RJ; Kolkman JJ; Suryapranata H; Hoorntje JC; Dambrink JH; Ottervanger JP; Gosselink AT; de Boer MJ; van 't Hof AW;
    Am Heart J; 2006 May; 151(5):1102-7. PubMed ID: 16644344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty.
    Bilsel T; Akbulut T; Yesilcimen K; Terzi S; Sayar N; Dayi SU; Akgoz H; Ergelen M; Ciloglu F
    Heart Vessels; 2006 Mar; 21(2):102-7. PubMed ID: 16550311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kırma C; Erkol A; Pala S; Oduncu V; Dündar C; İzgi A; Tigen K; Gibson CM
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):59-67. PubMed ID: 21523892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
    Han Y; Guo J; Zheng Y; Zang H; Su X; Wang Y; Chen S; Jiang T; Yang P; Chen J; Jiang D; Jing Q; Liang Z; Liu H; Zhao X; Li J; Li Y; Xu B; Stone GW;
    JAMA; 2015 Apr; 313(13):1336-46. PubMed ID: 25775052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
    Zhu TQ; Zhang Q; Ding FH; Qiu JP; Jin HG; Jiang L; Lu L; Zhang RY; Hu J; Yang ZK; Shen Y; Shen WF
    Chin Med J (Engl); 2013 Aug; 126(16):3079-86. PubMed ID: 23981616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Zhang Y; Gao C; Liu H; Wang X; Yang H; Li M; Wang X; Zhu Z; Hu D
    Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):289-94. PubMed ID: 23551127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of intracoronary tirofiban in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Wu TG; Zhao Q; Huang WG; Wei JR; Chen SW; Zhao J; Huang LP; Wang LX
    Circ J; 2008 Oct; 72(10):1605-9. PubMed ID: 18753700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of upstream tirofiban versus downstream tirofiban on platelet aggregation and clinical outcomes in patients with high-risk acute coronary syndromes undergoing percutaneous coronary interventions].
    Xie Y; Liu T; Zhou YJ; Ma HY; Guo YH; Li YP; Cheng WJ; Liu YY; Zhao YX; Shi DM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):39-43. PubMed ID: 19671350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI.
    Kaymaz C; Keleş N; Özdemir N; Tanboğa İH; Demircan HC; Can MM; Koca F; İzgi İA; Özkan A; Türkmen M; Kırma C; Esen AM
    Anatol J Cardiol; 2015 Nov; 15(11):899-906. PubMed ID: 25868037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
    ten Berg JM; van 't Hof AW; Dill T; Heestermans T; van Werkum JW; Mosterd A; van Houwelingen G; Koopmans PC; Stella PR; Boersma E; Hamm C;
    J Am Coll Cardiol; 2010 Jun; 55(22):2446-55. PubMed ID: 20510211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Ernst NM; Suryapranata H; Miedema K; Slingerland RJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; de Boer MJ; Zijlstra F; van 't Hof AW
    J Am Coll Cardiol; 2004 Sep; 44(6):1187-93. PubMed ID: 15364318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.